Santambrogio, L; Pakaski, M; Wong, M L et al. (1999) Antigen presenting capacity of brain microvasculature in altered peptide ligand modulation of experimental allergic encephalomyelitis. J Neuroimmunol 93:81-91
|
Lees, M B (1998) A history of proteolipids: a personal memoir. Neurochem Res 23:261-71
|
Santambrogio, L; Lees, M B; Sobel, R A (1998) Altered peptide ligand modulation of experimental allergic encephalomyelitis: immune responses within the CNS. J Neuroimmunol 81:1-13
|
Greer, J M; Klinguer, C; Trifilieff, E et al. (1997) Encephalitogenicity of murine, but not bovine, DM20 in SJL mice is due to a single amino acid difference in the immunodominant encephalitogenic epitope. Neurochem Res 22:541-7
|
Stephens, T S; Pakaski, M; Lees, M B et al. (1996) Identification and characterization of a B-cell determinant within the amphipathic domain (residues 178-238) of the myelin proteolipid protein. J Neurosci Res 43:545-53
|
Encinas, J A; Lees, M B; Sobel, R A et al. (1996) Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J Immunol 157:2186-92
|
Greer, J M; Sobel, R A; Sette, A et al. (1996) Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 156:371-9
|
Greer, J M; Dyer, C A; Pakaski, M et al. (1996) Orientation of myelin proteolipid protein in the oligodendrocyte cell membrane. Neurochem Res 21:431-40
|
Nicholson, L B; Greer, J M; Sobel, R A et al. (1995) An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397-405
|
Genain, C P; Nguyen, M H; Letvin, N L et al. (1995) Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 96:2966-74
|
Showing the most recent 10 out of 39 publications